Tarsus Pharmaceuticals Stock Options Expiring on 17th of January

TARS Stock  USD 49.91  0.36  0.73%   

Tarsus Total Stockholder Equity

Total Stockholder Equity

147.68 Million

At this time, Tarsus Pharmaceuticals' Total Stockholder Equity is comparatively stable compared to the past year.

Tarsus Pharmaceuticals Corporate Management

Leonard JDChief OfficerProfile
Scott YoumansVice SalesProfile
Seshadri NeervannanChief OfficerProfile
Adrienne KempSenior CommunicationsProfile
Elizabeth MDChief DirectorProfile
Aziz MBAChief OfficerProfile

Additional Tools for Tarsus Stock Analysis

When running Tarsus Pharmaceuticals' price analysis, check to measure Tarsus Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tarsus Pharmaceuticals is operating at the current time. Most of Tarsus Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Tarsus Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tarsus Pharmaceuticals' price. Additionally, you may evaluate how the addition of Tarsus Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.